Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of obesity. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://lewisvlwc647369.bcbloggers.com/37907415/trelaglutide-exploring-a-new-therapy-for-chronic-diseases